Pfizer's Lyrica fails in postmarketing study; Gilead sales of hep C drugs may surprise;

@FiercePharma: Mylan recalls drug after problem uncovered with Indian supplier. FiercePharmaManufacturing article | Follow @FiercePharma

@EricPFierce: DEA says it is not the cause of shortages of scheduled drugs, that it is just misunderstood. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI: Glaxo to reap $890M as it halves stake in South Africa's Aspen. Story | Follow @CarlyHFierce

> Pfizer's ($PFE) blockbuster pain drug Lyrica failed a postmarketing study testing the treatment in adolescents with fibromyalgia; the drug is already approved to treat the condition in adults. Report

> New IMS data shows total prescriptions of Gilead Sciences' ($GILD) hepatitis-C treatments growing by 2.1% last week leading ISI analyst Mark Schoenebaum to think its first-quarter sales could surprise to the upside. Blog

> The Lebanese health minister filed lawsuits against Pfizer and Mectapharm, a distributor, for overcharging the state for medication used to treat Parkinson's disease. Story

Medical Device News

@FierceMedDev: 23andMe launches new therapeutics group with biotech vet taking the reins. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Irish research center wins EU funding to study and develop transdermal delivery methods. More from FierceDrugDelivery | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: FDA calls for panel meeting to discuss devices linked to superbug outbreak. Article | Follow @EmilyWFierce

> Zimmer recalls part of Persona--a total knee replacement that helped drive 2014 growth. More

> Medtronic launches U.S. clinical trial of its newest drug-eluting stent. Article

Biotech News

@FierceBiotech: EuroBiotech: Sanofi backs immunotherapy hub, U.K. mulls its own 'breakthrough,' Allergy player banks £20M. Report | Follow @FierceBiotech

@JohnCFierce: Coming up on 500 responses to our survey question: Sustainable bull market or biotech bubble? Let's hear from you. Survey | Follow @JohnCFierce

@DamianFierce: Science RT @NYTArchives: An unlucky kitten is volunteered to test weightlessness inside an F-94C at 25,000 feet, 1958. Picture | Follow @DamianFierce

> Biogen Idec trims R&D staff, looks for new talent in chemistry, neurology. More

> Third Rock's faded Ember gets resuscitated in merger deal. Report